MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Predictive Oncology ROE Ratio 2011-2026 | POAI
Annual ROE Ratio Predictive Oncology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -488.5 | 6250.62 | -169.06 | -118.25 | -48.82 | -979.47 | -172.65 | -18863.1 | -287.77 | -706.52 | -116.48 | 123.88 | 292.24 | 224.85 | 166.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6250.62 | -18863.1 | -992.85 |
Quarterly ROE Ratio Predictive Oncology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1743.72 | 1486.1 | 1283.17 | -339.11 | -366.26 | -236.08 | -185.06 | -72.27 | -85.99 | -72.56 | -76.86 | -53.77 | -65.15 | -62.81 | -36.67 | -27.17 | -265.86 | -493.16 | -623.68 | -545.45 | -581.14 | -378.14 | -229.73 | -51.97 | -4740.16 | -9392.66 | -13844.3 | -12418.28 | -12455.13 | -7803.8 | -3459.69 | -419.12 | -1125.64 | -1795.31 | -2407.34 | -2119.57 | -2236.05 | -1646.01 | -968.3 | -150.79 | -130.58 | 6.12 | 66.41 | 81.0 | 204.5 | 307.79 | 312.85 | 225.32 | 311.78 | 274.73 | 302.86 | 172.71 | 190.37 | 121.58 | 74.58 | 201.3 | 17.66 | 17.66 | 165.98 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1743.72 | -13844.3 | -1260.91 |
ROE Ratio of other stocks in the Medical instruments industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
4.55 | $ 60.79 | 0.68 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
7991.72 | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
-29.17 | $ 115.17 | 0.88 % | $ 3.69 B | USA |
 |
Luminex Corporation
LMNX
|
2.93 | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
0.03 | $ 121.75 | -1.01 % | $ 3 B | USA |
 |
Repro Med Systems
KRMD
|
-15.47 | $ 3.89 | -2.26 % | $ 180 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
-50.84 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
16.02 | $ 426.62 | -0.34 % | $ 152 B | USA |
 |
LeMaitre Vascular
LMAT
|
14.66 | $ 99.14 | -0.36 % | $ 2.24 B | USA |
 |
Alcon
ALC
|
-2.82 | $ 64.53 | 0.8 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
-28.99 | $ 178.4 | 0.03 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
47.18 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.88 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-23.1 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
12.92 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-129.56 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.51 | $ 23.88 | 0.13 % | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
16.51 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
817.2 | $ 6.3 | -2.02 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
20.43 | $ 56.86 | -0.4 % | $ 2.86 B | USA |
 |
STAAR Surgical Company
STAA
|
-23.37 | $ 31.88 | -0.42 % | $ 1.58 B | USA |
 |
STERIS plc
STE
|
9.31 | $ 215.75 | -0.17 % | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
-28.98 | $ 130.11 | -0.13 % | $ 5.81 B | USA |
 |
Isoray
ISR
|
-49.81 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-29.16 | $ 142.59 | 0.3 % | $ 6.91 B | USA |
 |
InfuSystem Holdings
INFU
|
11.56 | $ 8.53 | -1.24 % | $ 176 M | USA |
 |
Microbot Medical
MBOT
|
-16.95 | $ 1.92 | 3.51 % | $ 87.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
-203.45 | $ 0.34 | -0.15 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
8.11 | $ 62.51 | -0.08 % | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
2.15 | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
15.54 | $ 302.94 | 0.92 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
-90.24 | $ 24.97 | -7.88 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-44.66 | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
-16.89 | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
24.51 | $ 59.29 | 1.09 % | $ 195 M | USA |
 |
BioLife Solutions
BLFS
|
-1.24 | $ 20.77 | -1.36 % | $ 992 M | USA |
 |
Stereotaxis
STXS
|
-160.54 | $ 1.88 | -3.34 % | $ 171 M | USA |
 |
Baxter International
BAX
|
-15.61 | $ 17.56 | -1.29 % | $ 9.01 B | USA |
 |
ResMed
RMD
|
23.19 | $ 204.64 | 1.03 % | $ 29.9 B | USA |
 |
AtriCure
ATRC
|
-2.33 | $ 28.64 | 1.72 % | $ 1.37 B | USA |
 |
Harvard Bioscience
HBIO
|
-412.84 | $ 5.48 | -0.69 % | $ 243 M | USA |
 |
NeuroMetrix
NURO
|
-54.54 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-18.58 | $ 11.01 | -0.18 % | $ 450 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.61 | $ 143.69 | -0.57 % | $ 41.3 B | USA |
 |
Nephros
NEPH
|
11.7 | $ 3.21 | -3.94 % | $ 34.1 M | USA |
 |
OraSure Technologies
OSUR
|
-20.17 | $ 3.04 | 3.05 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
2.32 | $ 105.54 | 2.09 % | $ 5.93 M | USA |